Wisconsin [US], January 27 (ANI): A new study has found the drugs behind the new pills to treat COVID-19 remain very effective against the Omicron variant of the virus in lab tests.
New Delhi [India], January 24 (ANI): India's top virologist, Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific"
Washington [US], January 23 (ANI): In view of the spike in COVID-19 infections globally, a recent study shed light on the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV-2.
Thiruvananthapuram (Kerala) [India], January 19 (ANI): The rising cases of COVID-19 in Kerala could be due to the presence of the Omicron variant of the virus, said Dr GS Vijayakrishnan, the President of Kerala Government Medical Officers Association on Tuesday.
New Delhi [India], January 18 (ANI): According to the revised guidelines issued by AIIMS, ICMR - COVID 19 National Task Force and Joint Monitoring Group (DGHS) under Union Health Ministry for management of adult COVID-19 patients, there is no evidence of injectable steroids in those who does
Kolkata (West Bengal) [India], January 5 (ANI): Amid the surge in COVID cases and concerns over the Omicron variant of coronavirus, doctors in Kolkata believe that there is no requirement for antibody cocktail for most of the patients as the formula is not useful for the Omicron variant of c
Moscow [Russia], December 17 (ANI): Russian Direct Investment Fund (RDIF) on Friday said that Sputnik V and Sputnik Light vaccines induce robust neutralizing antibody response to COVID-19 variant Omicron.
New Delhi [India], December 9 (ANI): AstraZeneca's Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected t
Washington [US], December 8 (ANI/Sputnik): Antibody measurements shortly after people were vaccinated against COVID-19 revealed the potential for speedier clinical trials of new vaccine candidates with fewer participants, the National Institutes of Health (NIH) said.
Washington [US], November 22 (ANI): A new study has found that people who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors (a class of immunosuppressants), generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people
Brussels [Belgium], November 11 (ANI/Sputnik): The European Medicines Agency recommended on Thursday authorizing two antibody medicines, Ronapreve and Regkirona, for COVID-19 treatment in patients who are at risk of their disease becoming severe.
Washington [US], November 3 (ANI): Researchers at the University of Maryland School of Medicine (UMSOM) have detected antibodies primarily made in response to infections in the mucous membranes -- in such areas as the lungs, intestines, or vagina -- in study participants with malaria.